Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis

por Merola, J.F., Ghislain, P.‐D., Dauendorffer, J.N., Potts Bleakman, A., Brnabic, A.J.M., Burge, R., Riedl, E.
Publicado 2020

Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database

por Chan, D.-C., Chang, C. H.-C., Lim, L.-C., Brnabic, A. J. M., Tsauo, J.-Y., Burge, R., Hsiao, F.-Y., Jin, L., Gürbüz, S., Yang, R.-S.
Publicado 2016